Boardroom Alpha
10-K primary document
SBRA · Annual Report (Form 10-K) · Filed February 12, 2026

Sabra Health Care REIT Inc10-K exhibit

exhibit1071.htm
exhibit1071
[SIGNATURE PAGE TO AMENDMENT] 4911-5322-3045.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into this 1st day of January, 2026 (the “Amendment Effective Date”), by and between Michael L. Costa (“Executive”) and Sabra Health Care REIT, Inc., a Maryland corporation (“Sabra” or the “Company”). WHEREAS, pursuant to that certain Employment Agreement, dated January 1, 2022, between Executive and the Company (the “Employment Agreement”), Executive currently serves as Sabra’s Executive Vice President, Chief Financial Officer (“CFO”) and Secretary; WHEREAS, Executive has been appointed as Treasurer as of the Amendment Effective Date; WHEREAS, Executive is relinquishing his title and role as Secretary effective as of the Amendment Effective Date. NOW, THEREFORE, in consideration of the above recitals, Executive and Sabra hereby amend the Employment Agreement, effective as of the Amendment Effective Date, by replacing all references in Sections 2 and 4 of the Employment Agreement to the term “Secretary” with the term “Treasurer”. The Company and Executive agree and confirm that all provisions of the Employment Agreement, as modified by this Amendment, remain in full force and effect in accordance with their respective terms. The parties hereto have executed this Amendment as of the Amendment Effective Date. MICHAEL L. COSTA SABRA HEALTH CARE REIT, INC. By: Richard K. Matros Its: Chief Executive Officer, President and Chair /s/ Michael L. Costa /s/ Richard K. Matros


 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer